Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Cancer Immunol Res. 2018 Nov;6(11):1327-1336. doi: 10.1158/2326-6066.CIR-18-0174. Epub 2018 Sep 18.
The presence of () in colorectal carcinoma tissue has been associated with microsatellite instability (MSI), lower-level T-cell infiltrates, and poor clinical outcomes. Considering differences in the tumor-immune microenvironment between MSI-high and non-MSI-high carcinomas, we hypothesized that the association of with immune response might differ by tumor MSI status. Using samples from 1,041 rectal and colon cancer patients within the Nurses' Health Study and Health Professionals Follow-up Study, we measured DNA in tumor tissue by a quantitative polymerase chain reaction assay. Multivariable logistic regression models were used to examine the association between status and histopathologic lymphocytic reactions or density of CD3 cells, CD8 cells, CD45RO (PTPRC) cells, or FOXP3 cells in strata of tumor MSI status. We adjusted for potential confounders, including CpG island methylator phenotype; LINE-1 methylation; and , and mutations. The association of with tumor-infiltrating lymphocytes (TIL) and intratumoral periglandular reaction differed by tumor MSI status ( = 0.002). The presence of was negatively associated with TIL in MSI-high tumors [multivariable odds ratio (OR), 0.45; 95% confidence interval (CI), 0.22-0.92], but positively associated with TIL in non-MSI-high tumors (multivariable OR 1.91; 95% CI, 1.12-3.25). No significant differential association was observed for peritumoral lymphocytic reaction, Crohn-like lymphoid reaction, or T-cell densities. In conclusion, the association of with immune response to colorectal carcinoma differs by tumor MSI status, suggesting that and MSI status interact to affect antitumor immune reactions. .
结直肠癌组织中 ()的存在与微卫星不稳定(MSI)、较低水平的 T 细胞浸润和较差的临床结局相关。考虑到 MSI 高和非 MSI 高型癌之间肿瘤免疫微环境的差异,我们假设与免疫反应的关联可能因肿瘤 MSI 状态而异。我们使用来自护士健康研究和健康专业人员随访研究的 1041 例直肠和结肠癌患者的样本,通过定量聚合酶链反应检测肿瘤组织中的 DNA。多变量逻辑回归模型用于检查 状态与组织病理学淋巴细胞反应或 CD3 细胞、CD8 细胞、CD45RO(PTPRC)细胞或 FOXP3 细胞密度之间的关联,这些细胞在肿瘤 MSI 状态的分层中。我们调整了潜在的混杂因素,包括 CpG 岛甲基化表型;LINE-1 甲基化;和 、和 突变。与肿瘤浸润淋巴细胞(TIL)和肿瘤内围腺反应的关联因肿瘤 MSI 状态而异(=0.002)。在 MSI 高肿瘤中, 的存在与 TIL 呈负相关(多变量比值比[OR],0.45;95%置信区间[CI],0.22-0.92),但在非 MSI 高肿瘤中与 TIL 呈正相关(多变量 OR,1.91;95%CI,1.12-3.25)。未观察到肿瘤周围淋巴细胞反应、克罗恩样淋巴样反应或 T 细胞密度的显著差异关联。总之,结直肠癌中 与免疫反应的关联因肿瘤 MSI 状态而异,这表明 和 MSI 状态相互作用影响抗肿瘤免疫反应。